SAB also has therapeutic effects on a variety of cancers, such as lung, breast, oral squamous cell carcinoma, head and neck cancer, hepatocellular carcinoma, and glioma cancer cell lines. Here, SH3BP5 is linked to oral cavity squamous cell carcinoma.